Waystar Holding Corp. (NASDAQ:WAY) is a promising mid-cap healthcare stock under $50, with UBS analyst Kevin Caliendo initiating coverage on December 15. Caliendo sees a 25% upside potential with a Buy rating and a $41 price target. The market sentiment is positive, with 16 Buy ratings and a 47.5% estimated upside.

Caliendo’s Buy rating for Waystar Holding Corp. (NASDAQ:WAY) is based on strategic factors like market position and growth prospects in revenue cycle management. The company’s AI-enabled automation and acquisition of Iodine Software for inorganic growth are key strengths. The stock has 17 analysts covering it, with a 1-year price target of $48.44.

Waystar Holding Corp. (NASDAQ:WAY) offers cloud-based software for healthcare payment processing, covering the entire revenue cycle. Despite potential as an investment, some AI stocks offer greater upside potential and less downside risk. Investors seeking undervalued AI stocks should consider other options for potential growth.

Read more at Yahoo Finance: AI-Enabled Automation Driving Up Sentiment Towards Waystar (WAY)